Glavamet-GR is a fixed dose combination of Glimepiride (Sulfonylurea) and Metformin (Biguanide) which shows greater efficacy in reaching the metabolic goal of glycaemic control with less hypoglycaemic events in patients with  Type-2 Diabetes Mellitus.